ZimVie
-
Financial
ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results
FY 2023 Third Party Net Sales from Continuing Operations of $457.2 million FY 2023 Third Party Net Sales from Discontinued…
Read More » -
Financial
ZimVie Announces Definitive Agreement to Sell Spine Business to H.I.G. Capital for $375 Million
Proposed Sale Establishes a Pure-Play Dental Company with a Leading Implant Portfolio Net Proceeds Will be Used to Pay Down…
Read More » -
Regulatory
ZimVie Announces Compatibility Between its Vital™ Spinal Fixation System and Brainlab Spine & Trauma Navigation
WESTMINSTER, Colo., Dec. 12, 2023 (GLOBE NEWSWIRE) — ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental…
Read More » -
Spine
ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study
Decision clears the way for enrollment of U.S. patients in a groundbreaking clinical study of cervical arthroplasty adjacent to fusion…
Read More » -
Spine
ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing
ZimVie and Brainlab will cooperate on achieving compatibility between ZimVie’s Vital™ and Virage® fixation systems with the Brainlab spine and trauma…
Read More » -
Regulatory
ZimVie Announces FDA Approval for New Mobi-C® Implant
Smaller height implants in all Mobi-C footprints to address patient anatomy WESTMINSTER, Colo., Aug. 10, 2023 (GLOBE NEWSWIRE) — ZimVie…
Read More » -
Financial
ZimVie Reports Second Quarter 2023 Financial Results and Provides Update to Annual Guidance
Third Party Net Sales of $224.9 millionNet Loss of ($23.4) million; Net Loss Margin of (10.4%); Adjusted Net Income[1] of $4.3…
Read More » -
Spine
ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C®
Mobi-C obtains French government reimbursement and the highest quality rating from the British clinical data panel ODEP. WESTMINSTER, Colo., April…
Read More » -
Spine
ZimVie Announces Additional Positive Policy Decisions for Vertebral Body Tethering
The Tether™ device now deemed “medically necessary” for the treatment of pediatric scoliosis in additional patients covered by Highmark and…
Read More » -
Financial
ZimVie Reports Fourth Quarter and Full Year 2022 Financial Results
FY 2022 Third Party Net Sales of $909.5 millionFY 2022 Net Loss of ($63.9) million; Net Loss Margin of (7.0%);…
Read More » -
Financial
ZimVie to Report Fourth Quarter and Full Year 2022 Financial Results on March 1, 2023
WESTMINSTER, Colo., Feb. 13, 2023 (GLOBE NEWSWIRE) — ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental…
Read More » -
Spine
ZimVie Announces Over 200,000 Cervical Discs Have Been Replaced with Mobi-C®
Milestone aligns with ten-year anniversary of Mobi-C FDA approval for treatment of one and two levels of the cervical spine…
Read More » -
Financial
ZimVie Reports Third Quarter 2022 Financial Results
Third party net sales of $213.3 millionNet income of $0.8 million; net income margin of 0.4%; adjusted net income[1] of $12.9…
Read More » -
Spine
ZimVie Expands Navigation-Compatible Platform to Include Posterior Cervical Application
The Virage® Navigation System Rounds out ZimVie’s Ability to Navigate Pedicle Screws in the Entire Spine. WESTMINSTER, Colo., Oct. 11,…
Read More » -
Spine
ZimVie Announces Positive Policy Decision from Anthem for Anterior Vertebral Body Tethering, Expanding Coverage to 30+ Million Lives
The Tether™ device now considered “medically necessary” for treatment of pediatric scoliosis. WESTMINSTER, Colo., July 12, 2022 (GLOBE NEWSWIRE) —…
Read More »